Back
Prelude Therapeutics Quote, Financials, Valuation and Earnings
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
21
PRLD
Prelude Therapeutics
Last Price:
1.15
Seasonality Move:
21.44%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HerePrelude Therapeutics Price Quote
$1.15
-0.05 (-3.77%)
(Updated: November 12, 2024 at 5:55 PM ET)
Prelude Therapeutics Key Stats
Sell
21
Prelude Therapeutics (PRLD)
is a Sell
Day range:
$1.19 - $1.24
52-week range:
$1.10 - $6.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.42%
Volume:
282.9K
Avg. volume:
307.4K
1-year change:
-60.3%
Market cap:
$65.8M
Revenue:
$0
EPS:
$-1.78
How Much Does Prelude Therapeutics Make?
Data Unavailable
Is Prelude Therapeutics Growing As A Company?
Data Unavailable
Prelude Therapeutics Stock Price Performance
-
Did Prelude Therapeutics Stock Go Up Last Month?
Prelude Therapeutics share price went down by -38.87% last month -
Did PRLD's Share Price Rise Over The Last Year?
PRLD share price fell by -60.3% over the past 1 year
What Is Prelude Therapeutics 52-Week High & Low?
-
What Is Prelude Therapeutics’s 52-Week High Share Price?
Prelude Therapeutics has traded as high as $6.80 over the past 52 weeks -
What Is Prelude Therapeutics’s 52-Week Low Share Price?
Prelude Therapeutics has traded as low as $1.10 over the past 52 weeks
Prelude Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Prelude Therapeutics?
-
How Much Debt Does Prelude Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Prelude Therapeutics Have?
Cash and short term investments quarterly total is $153.6M -
What Is Prelude Therapeutics’s Book Value Per Share?
Book value per share is 2.84
Is Prelude Therapeutics Cash Flow Positive?
-
What Is PRLD Cash Flow From Operations?
Cash flow from operations (TTM) is -$105.7M -
What Is Prelude Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $25.2M -
What Is Prelude Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $75.8M
Prelude Therapeutics Return On Invested Capital
Data Unavailable
Prelude Therapeutics Earnings Date & Stock Price
-
What Is Prelude Therapeutics's Stock Price Today?
A single share of PRLD can be purchased today for 1.20 -
What Is Prelude Therapeutics’s Stock Symbol?
Prelude Therapeutics trades on the nasdaq under the ticker symbol: PRLD -
When Is Prelude Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Prelude Therapeutics is scheduled on February 14, 2025 -
When Is PRLD's next ex-dividend date?
Prelude Therapeutics's next ex-dividend date is November 13, 2024 -
How To Buy Prelude Therapeutics Stock?
You can buy Prelude Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Prelude Therapeutics Competitors
-
Who Are Prelude Therapeutics's Competitors?
Below is a list of companies who compete with Prelude Therapeutics or are related in some way:
Prelude Therapeutics Dividend Yield
-
What Is PRLD Dividend Yield?
Prelude Therapeutics’s dividend yield currently is 0% -
What Is Prelude Therapeutics’s Payout Ratio?
Prelude Therapeutics’s payout ratio is 0% -
When Did Prelude Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 13, 2024 -
What Is Prelude Therapeutics’s Dividend Per Share?
Prelude Therapeutics pays a dividend of $0.00 per share
Prelude Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 7.48% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 1 |
| Price Target: | 5.40 |
| Upside from Last Price: | 351.88% |